Physician profile
Paul B Pruett
NPI 1164611513
$54,409.83
in general payments reported to CMS, 2019-2025
30 companies · $3,084 in 2025
The $3,084 reported for 2025 was more than what 87% of Glaucoma Specialist providers received nationally (typical 2025 total: $608).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $685 · 2021: $6,564 · 2022: $8,216 · 2023: $6,576 · 2024: $7,870 · 2025: $3,084.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $11K · Food and Beverage: $3,920 · Consulting Fee: $1,275 · Travel and Lodging: $1,246 · Gift: $14.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $11,075.00 |
| Food and Beverage | $3,919.92 |
| Consulting Fee | $1,275.00 |
| Travel and Lodging | $1,245.65 |
| Gift | $14.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $26,580.91 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $21,307.93 | 2022-2025 | Vyzulta, Miebo |
| Abbvie INC. | $1,244.23 | 2022-2025 | |
| Allergan, INC. | $966.23 | 2019-2022 | |
| Alcon Vision LLC | $831.60 | 2019-2025 | Rocklatan, Hydrus Microstent, Rhopressa |
| Sight Sciences, INC. | $432.18 | 2019-2025 | Omni Surgical System |
| Tarsus Pharmaceuticals, INC. | $366.54 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $350.80 | 2022-2025 | Tyrvaya |
| New World Medical,INC. | $342.15 | 2022-2025 | Ahmed Glaucoma Valve, Kahook Dual Blade, Clearpath |
| Novartis Pharmaceuticals Corporation | $244.20 | 2019-2023 | |
| Johnson & Johnson Surgical Vision, INC. | $220.02 | 2022-2025 | Tecnis Iol, Catalys System |
| Regeneron Pharmaceuticals, INC. | $213.94 | 2021-2024 | Eylea Hd |
| Rxsight INC | $205.48 | 2022-2024 | Rxsight Injector Handpiece, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Aerie Pharmaceuticals, INC. | $193.24 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $185.97 | 2019-2025 | Cequa |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ivantis, INC | $130.47 | 2019-2020 | |
| Genentech, INC. | $88.33 | 2025 | Susvimo |
| Eyepoint US, INC. | $82.95 | 2022 | |
| Ocular Therapeutix, INC. | $79.74 | 2024-2025 | Dextenza |
| Rayner Intraocular Lenses Limited | $71.08 | 2022-2023 | Rayone Spheric, Rayone Aspheric, Rayone Emv |
| Apellis Pharmaceuticals, INC. | $64.74 | 2025 | Syfovre |
| Carl Zeiss Meditec USA, INC. | $38.18 | 2024 | Iolmaster 700 |
| Dompe US, INC. | $37.40 | 2019-2025 | Oxervate |
| Harrow Eye, LLC | $30.48 | 2024 | Vevye |
| Thea Pharma INC. | $24.92 | 2023 | Iyuzeh |
| Mallinckrodt Hospital Products INC. | $18.25 | 2021 | |
| Topcon Healthcare Solutions, INC. | $17.42 | 2020 | |
| Biotissue Holdings INC. | $15.50 | 2019 | |
| Horizon Therapeutics Plc | $15.36 | 2019 | |
| Iridex Corporation | $9.59 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Pruett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.